ORBIMED ADVISORS LLC 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-29 4:16 pm Sale |
2023-12-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 2,680,496 4.600% |
-1,546,347 (-36.58%) |
Filing |
| 2023-11-13 08:51 am Purchase |
2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,226,843 7.300% |
145,251 (+3.56%) |
Filing |
| 2022-09-27 4:29 pm Sale |
2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,081,592 9.300% |
-145,251 (-3.44%) |
Filing |
| 2021-11-12 5:05 pm Purchase |
2021-11-10 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,226,843 14.400% |
1,010,637 (+31.42%) |
Filing |
| 2020-12-30 4:27 pm Sale |
2020-12-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 3,216,206 13.400% |
-600,000 (-15.72%) |
Filing |
| 2020-07-30 6:26 pm Unchanged |
2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 3,816,206 16.000% |
0 (Unchanged) |
Filing |